Richard D. Carvajal

机构：Northwell Health, Cold Spring Harbor Laboratory, Columbia University Irving Medical Center, North Shore Diabetes and Endocrine Associates · ORCID：0000-0002-3796-1118

发表论文 708 篇 · 总被引 40143 次 · h-index 75

代表论文

• Evolution of the tumor immune landscape during treatment with tebentafusp, a T cell receptor-CD3 bispecific (2025 · Cell Reports Medicine · 被引 14)
• Phase I Clinical Trial of the Bifunctional EGFR/TGF-β Fusion Protein Ficerafusp Alfa (BCA101) Alone and in Combination with Pembrolizumab for Advanced Solid Tumors (2025 · Clinical Cancer Research · 被引 7)
• Concurrent local therapy extends clinical benefit of tebentafusp in metastatic uveal melanoma patients (2025 · The Oncologist · 被引 6)
• Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients (2025 · Clinical Cancer Research · 被引 5)
• Melanoma and other skin cancers (2025 · 被引 5)
• Translating ctDNA into cutaneous melanoma care: An international expert survey (2026 · European Journal of Cancer · 被引 3)